HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotactic behaviour of peripheral and synovial neutrophils during rifamycin SV therapy in rheumatoid arthritis.

Abstract
The effect exerted by rifamycin SV, used intra-articularly in the treatment of rheumatoid arthritis, on polymorph function was studied. Random and directional locomotion of synovial fluid neutrophils was compared with that of peripheral blood cells in 10 patients followed up during 5 drug applications. PMNs from the two sources were characterized by different responsiveness to this pharmacological agent: blood cells activated chemotaxis in a dose-response way during rifamycin therapy, whereas synovial polymorphs did not modify their locomotor behaviour. It is proposed that the presence of immune complexes and/or factors produced by cell-cell interactions in the articular space may change the synovial neutrophil response to stimuli.
AuthorsS Spisani, L Dovigo, C Marangoni, S Traniello
JournalJournal of clinical & laboratory immunology (J Clin Lab Immunol) Vol. 14 Issue 2 Pg. 111-4 (Jun 1984) ISSN: 0141-2760 [Print] Scotland
PMID6748046 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Rifamycins
Topics
  • Adolescent
  • Adult
  • Aged
  • Arthritis, Rheumatoid (drug therapy)
  • Cell Movement
  • Chemotaxis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neutrophils (immunology, physiology)
  • Random Allocation
  • Rifamycins (therapeutic use)
  • Synovial Fluid (cytology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: